Sbir phase i: oral delivery systems for sterilizing strains of a sexually-transmitted insect virus
Ended Project Grant Awarded Last action
- Award ID
- 2126953
- Recipient
-
Lepidext, Inc. UEI NQA9H9Z389N4
- Awarding agency
-
Division of Industrial Innovation
National Science Foundation
- Obligated
- $256,000
Award facts
- Assistance listing
- 47.041 Engineering
- Completion date
- Place of performance
- Lexington, KY 40505, USA
Award details come from USAspending.gov.
About this award
The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to Lexington, KY-based Lepidext, Inc. under the Engineering (47.041) federal grant program. The grant will support Lepidext's SBIR Phase I project to develop oral delivery systems for sterilizing strains of a sexually-transmitted insect virus. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. The 12-month project period runs from January 1, 2022 to December 31, 2022 and will fund Lepidext's initial research toward developing novel oral formulations to deliver insect viruses as a means of controlling insect-borne diseases.
Quick answers
Who received award 2126953?
2126953 was awarded to Lepidext, Inc. by Division of Industrial Innovation (National Science Foundation) on January 1, 2022.
How much is award 2126953 worth?
$256,000 has been obligated on 2126953.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award